4.8 Letter

Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers

Journal

LANCET
Volume 396, Issue 10246, Pages E6-E7

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/S0140-6736(20)31484-7

Keywords

-

Funding

  1. UCLH/UCL NIHR Biomedical Research Centre
  2. MRC UKRI [MC_PC_19082]
  3. Francis Crick Institute from Cancer Research UK [FC001169, FC001078]
  4. MRC [FC001169, FC001078]
  5. WellcomeTrust [FC001169, FC001078]
  6. Royal Society Napier Professorship
  7. Rosetrees Trust
  8. Breast Cancer Research Foundation
  9. Pfizer
  10. AstraZeneca
  11. BMS
  12. Roche-Ventana
  13. Boehringer Ingelheim
  14. Ono Pharmaceutical
  15. MRC [MR/R008698/1, MC_PC_19082, MR/T001127/1, MC_U117597139] Funding Source: UKRI

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available